Rocket Pharmaceuticals Inc (RCKT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

350 FIFTH AVENUE NEW YORK, NY 10118

Inotek Pharmaceuticals Corp produces and distributes pharmaceutical products. The Company specializes in developing molecules with novel mechanisms of action for the treatment of eye diseases. Inotek Pharmaceutical serves customers throughout the United States.

Data based on most recent fiscal year report
Market Cap1.075 Billion Shares Outstanding50.38 Million Avg Volume414.221 Thousand
1-Yr BETA vs S&P TR1.174 Current Ratio13.6 Quick Ratio13.6
View SEC Filings from RCKT instead.

View recent insider trading info

Funds Holding RCKT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RCKT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

380.9 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHAH GAURAV PRESIDENT & CEO

1,028,997 2020-03-24 3

MCVICAR WILLIAM K.

  • Director
0 2020-03-23 0

PATEL KINNARI CHIEF OPERATING OFFICER

213,340 2020-03-18 3

PHILLIPS GARY M.

  • Director
13,620 2020-03-04 0

SCHWARTZ JONATHAN DAVID CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-06 2

MILITELLO JOHN SEE REMARKS

  • Officer
0 2020-02-06 2

ALAM KAMRAN SVP - FINANCE & PFO

  • Officer
0 2020-02-06 3

SOUTHWELL DAVID P

  • Director
1,650 2020-01-29 0

MACHADO PATRICK

  • Director
0 2020-01-01 0

BARBERICH TIMOTHY J

  • Director
0 2019-12-16 0

WONG RODERICK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
902,498 2019-12-11 0

RTW INVESTMENTS, LP

WONG RODERICK

YALAMANCHI NAVEEN

  • Director
  • 10% Owner
17,282,324 2019-12-10 2

CARROLL J MARTIN

  • Director
23,849 2019-08-22 0

SPIVEY RICHARD N.

  • Director
0 2019-07-31 0

VOGELBAUM MARTIN

  • Director
6,000 2019-06-04 0

KARABELAS ARGERIS N

0 2019-05-31 0

MAKKER GOTHAM

  • Director
20,000 2019-05-09 0

GRANADILLO PEDRO P

  • Director
20,000 2019-05-09 0

YALAMANCHI NAVEEN VICE PRESIDENT AND CFO

  • Officer
  • Director
0 2019-05-09 0

BOESS CARSTEN

0 2019-01-28 0

BATCHELDER BRIAN SEE REMARKS

  • Officer
0 2018-01-04 0

MEDIMMUNE VENTURES, INC.

  • 10% Owner
2,950,630 2017-12-15 0

RITTER DALE VICE PRESIDENT, FINANCE

  • Officer
19,827 2017-09-14 0

HOWES PAUL G

  • Director
0 2017-06-20 0

BAUMGARTNER RUDOLF A SEE REMARKS

  • Officer
0 2017-01-23 0

DEVON PARK BIOVENTURES LP

DEVON PARK ASSOCIATES, L.P.

DEVON PARK ASSOCIATES, LLC

  • 10% Owner
No longer subject to file 2017-01-04 0

RHO VENTURES IV HOLDINGS LLC

RHO VENTURES IV-A, L.P.

  • 10% Owner
No longer subject to file 2015-11-16 0

DEVON PARK ASSOCIATES, L.P.

DEVON PARK ASSOCIATES, LLC

KANTESARIA DEVANG

  • 10% Owner
3,253,566 2015-07-14 0

PEIMER ISAI

  • Director
0 2015-06-24 0

CARE CAPITAL II LLC

CARE CAPITAL INVESTMENTS II LP

CARE CAPITAL OFFSHORE INVESTMENTS II LP

CARE CAPITAL III LLC

CARE CAPITAL INVESTMENTS III L.P.

CARE CAPITAL OFFSHORE INVESTMENTS III LP

  • 10% Owner
0 2015-06-24 0

HAREL ITTAI

  • Director
0 2015-06-24 0

KANTESARIA DEVANG

  • 10% Owner
3,243,709 2015-02-23 0

RHO VENTURES IV QP LP

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG

RHO VENTURES IV HOLDINGS LLC

RHO VENTURES IV LP

RHO VENTURES IV-A, L.P.

RHO MANAGEMENT VENTURES IV LLC

RHO CAPITAL PARTNERS VERWALTUNGS GMBH

KAIROUZ HABIB

RUCH JOSHUA

LESCHLY MARK

  • 10% Owner
2,870,584 2015-02-23 0

PITANGO VENTURE CAPITAL PRINCIPALS FUND IV, L.P.

PITANGO VENTURE CAPITAL FUND IV, L.P.

PITANGO V.C. FUND IV, L.P.

PITANGO G.C. CAPITAL HOLDINGS LTD.

  • 10% Owner
1,292,584 2015-02-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SHAH GAURAV PRESIDENT & CEO

2020-03-24 F 32,645 $13.78 d 1,028,997 1,028,997.00 direct

SHAH GAURAV PRESIDENT & CEO

2020-03-24 M 90,925 $0.43 a 1,061,642 1,028,997.00 direct

SHAH GAURAV PRESIDENT & CEO

2020-03-24 M 90,925 d 0 1,028,997.00 direct

PATEL KINNARI CHIEF OPERATING OFFICER by spouse

2020-03-18 P 1,000 $9.50 a 6,675 213,340.00 indirect

SHAH GAURAV - Director - Officer PRESIDENT & CEO

2020-02-25 M 290,000 d 90,925 970,717.00 direct

SHAH GAURAV - Director - Officer PRESIDENT & CEO

2020-02-25 F 6,233 $20.15 d 970,717 970,717.00 direct

SHAH GAURAV - Director - Officer PRESIDENT & CEO

2020-02-25 M 290,000 $0.43 a 976,950 970,717.00 direct

SCHWARTZ JONATHAN DAVID - Officer CHIEF MEDICAL OFFICER

2020-02-10 A 7,000 a 7,000 0.00 direct

PATEL KINNARI - Officer CHIEF OPERATING OFFICER

2020-02-10 A 15,000 a 15,000 0.00 direct

ALAM KAMRAN - Officer SVP - FINANCE & PFO

2020-02-10 A 3,000 a 3,000 0.00 direct

MILITELLO JOHN - Officer SEE REMARKS

2020-02-10 A 2,000 a 2,000 0.00 direct

SHAH GAURAV - Director - Officer PRESIDENT & CEO

2020-02-06 A 383,306 a 383,306 0.00 direct

MILITELLO JOHN - Officer SEE REMARKS

2020-02-06 A 20,000 a 20,000 0.00 direct

SCHWARTZ JONATHAN DAVID - Officer CHIEF MEDICAL OFFICER

2020-02-06 A 75,000 a 75,000 0.00 direct

PATEL KINNARI - Officer CHIEF OPERATING OFFICER

2020-02-06 A 150,000 a 150,000 0.00 direct

ALAM KAMRAN - Officer SVP - FINANCE & PFO

2020-02-06 A 25,000 a 25,000 0.00 direct

Elevate your investments